Brief: Elicera Therapeutics Q3 Adjusted EPS Sek 0.01
Nov 14 (Reuters) - Elicera Therapeutics AB ELIC.ST: Q3 ADJUSTED EPS SEK 0.01 REPORTS Q3 2025 OPERATING LOSS OF SEK 146,689 Source text: ID:nWkr5xHBqw Further company coverage: ELIC.ST (Gdansk Newsroom) ((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))
Recent news on Elicera Therapeutics AB
See all newsBrief: Elicera Therapeutics Completes Phase I Part Of Carma Study
Brief: Elicera Therapeutics Gets Medical Products Agency Approval To Advance CARMA Study
Brief: Elicera Gets Clearance To Use Highest ELC-301 Dose Ahead Of Phase IIa
Brief: Elicera Gets First Patent Allowance For ELC-201
Brief: Elicera Receives Notice Of Allowance For U.S. Patent Application